Assessing Pharmaceutical Research and Development Costs Reply

被引：0

|

作者：

Prasad, Vinay ^{[1
,2
,3
]}

Mailankody, Sham ^{[4
]}

机构：

[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA

[2] Oregon Hlth & Sci Univ, Dept Prevent Med & Publ Hlth, Portland, OR 97201 USA

[3] Oregon Hlth & Sci Univ, Ctr Hlth Care Eth, Portland, OR 97201 USA

[4] Mem Sloan Kettering Canc Ctr, Myeloma Serv, Div Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA

来源：

JAMA INTERNAL MEDICINE | 2018年 / 178卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：588 / 589

页数：2

相关论文

共 50 条

[1] Assessing Pharmaceutical Research and Development Costs
van der Gronde, Toon
Pieters, Toine
[J]. JAMA INTERNAL MEDICINE, 2018, 178 (04) : 587 - 588
[2] Methods Used to Assess Pharmaceutical Research and Development Costs
Ledley, Fred D.
[J]. JAMA INTERNAL MEDICINE, 2018, 178 (04) : 589 - 589
[3] RESEARCH AND DEVELOPMENT COSTS AND RETURNS - US PHARMACEUTICAL INDUSTRY
BAILY, MN
[J]. JOURNAL OF POLITICAL ECONOMY, 1972, 80 (01) : 70 - 85
[4] ASSESSING THE QUALITY OF PHARMACEUTICAL CARE - REPLY
FARRIS, KB
KIRKING, DM
[J]. ANNALS OF PHARMACOTHERAPY, 1993, 27 (12) : 1543 - 1543
[5] Pharmaceutical development costs skyrocket
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2001, 79 (50) : 14 - 14
[6] Assessing costs and benefits of PAPNET - Reply
Hutchinson, ML
[J]. ACTA CYTOLOGICA, 1996, 40 (05) : 1109 - 1111
[7] ASSESSING THE RESEARCH-AND-DEVELOPMENT CAPABILITY OF THE JAPANESE PHARMACEUTICAL-INDUSTRY
SAPIENZA, AM
[J]. R & D MANAGEMENT, 1993, 23 (01) : 3 - 16
[8] Demythologizing the high costs of pharmaceutical research
Light, Donald W.
Warburton, Rebecca
[J]. BIOSOCIETIES, 2011, 6 (01) : 34 - 50
[9] Pharmaceutical industry to share research costs
Kondro, Wayne
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (16) : E847 - E847
[10] Demythologizing the high costs of pharmaceutical research
Donald W Light
Rebecca Warburton
[J]. BioSocieties, 2011, 6 : 34 - 50

← 1 2 3 4 5 →